Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 449 followers

Latest posts

Last updated about 8 hours ago

Human medicines European public assessment report (EPAR): Yaxwer, denosumab, Date of authorisation: 23/06/2025, Revision: 2, Status: Authorised

10 days ago

Human medicines European public assessment report (EPAR): Yaxwer, denosumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Vislyfa, ranibizumab, Date of authorisation: 15/07/2026, Revision: 1, Status: Authorised

3 days ago

Human medicines European public assessment report (EPAR): Vislyfa, ranibizumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation: 16/12/2019, Revision: 35, Status: Authorised

3 days ago

Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation...

Human medicines European public assessment report (EPAR): Tagrisso, osimertinib, Date of authorisation: 01/02/2016, Revision: 25, Status: Authorised

1 day ago

Human medicines European public assessment report (EPAR): Tagrisso, osimertinib, Date of authorisation...

Human medicines European public assessment report (EPAR): Aybintio, bevacizumab, Date of authorisation: 19/08/2020, Revision: 13, Status: Authorised

about 11 hours ago

Human medicines European public assessment report (EPAR): Aybintio, bevacizumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Saphnelo, anifrolumab, Date of authorisation: 14/02/2022, Revision: 11, Status: Authorised

about 11 hours ago

Human medicines European public assessment report (EPAR): Saphnelo, anifrolumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Vyloy, zolbetuximab, Date of authorisation: 19/09/2024, Revision: 5, Status: Authorised

about 11 hours ago

Human medicines European public assessment report (EPAR): Vyloy, zolbetuximab, Date of authorisation...

Human medicines European public assessment report (EPAR): Repaglinide Accord, repaglinide, Date of authorisation: 22/12/2011, Revision: 8, Status: Withdrawn

about 11 hours ago

Human medicines European public assessment report (EPAR): Repaglinide Accord, repaglinide, Date of...

Human medicines European public assessment report (EPAR): Emgality, galcanezumab, Date of authorisation: 14/11/2018, Revision: 15, Status: Authorised

about 11 hours ago

Human medicines European public assessment report (EPAR): Emgality, galcanezumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Lynkuet, elinzanetant, Date of authorisation: 17/11/2025, Revision: 2, Status: Authorised

about 12 hours ago

Human medicines European public assessment report (EPAR): Lynkuet, elinzanetant, Date of authorisation...

Veterinary medicines European public assessment report (EPAR): AviGate S. Typhimurium, Salmonella enterica, subsp. enterica, serovar Typhimurium, strain Nal2/Rif9/Rtt, Live, Status: Opinion

about 15 hours ago

Veterinary medicines European public assessment report (EPAR): AviGate S. Typhimurium, Salmonella enterica...

Summary of opinion: Firocoxib CP-Pharma, 10/09/2026 Positive

about 15 hours ago

Summary of opinion: Firocoxib CP-Pharma, 10/09/2026 Positive